Recent developments with Geovax Labs Inc (GOVX) have led to the company’s beta value being reach 3.68 cents.

Shaun Noe

Geovax Labs Inc (NASDAQ: GOVX) on Friday, plunged -33.69% from the previous trading day, before settling in for the closing price of $0.24. Within the past 52 weeks, GOVX’s price has moved between $0.24 and $2.75.

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 78.99%. The company achieved an average annual earnings per share of 97.23%. With a float of $29.90 million, this company’s outstanding shares have now reached $30.06 million.

Geovax Labs Inc (GOVX) Insider and Institutional Ownership

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geovax Labs Inc is 0.52%, while institutional ownership is 11.37%. The most recent insider transaction that took place on Aug 07 ’25, was worth 742. In this transaction Chief Medical Officer of this company bought 1,107 shares at a rate of $0.67, taking the stock ownership to the 3,494 shares. Before that another transaction happened on Apr 10 ’25, when Company’s Director bought 10,000 for $0.98, making the entire transaction worth $9,800. This insider now owns 11,402 shares in total.

Geovax Labs Inc (GOVX) Latest Financial update

As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.3 earnings per share (EPS) for the period topping the consensus outlook (set at -0.77) by 0.47. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 97.23% per share during the next fiscal year.

Geovax Labs Inc (NASDAQ: GOVX) Trading Performance Indicators

Geovax Labs Inc (GOVX) is currently performing well based on its current performance indicators. A quick ratio of 3.57 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.43.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.89, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.09 in one year’s time.

Technical Analysis of Geovax Labs Inc (GOVX)

The latest stats from [Geovax Labs Inc, GOVX] show that its last 5-days average volume of 8.14 million was superior to 1.07 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 6.31%.

During the past 100 days, Geovax Labs Inc’s (GOVX) raw stochastic average was set at 6.44%, which indicates a significant decrease from 14.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0433 in the past 14 days, which was higher than the 0.0430 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.4588, while its 200-day Moving Average is $0.7891. Now, the first resistance to watch is $0.2363. This is followed by the second major resistance level at $0.3134. The third major resistance level sits at $0.3740. If the price goes on to break the first support level at $0.0986, it is likely to go to the next support level at $0.0380.

Geovax Labs Inc (NASDAQ: GOVX) Key Stats

Market capitalization of the company is 4.79 million based on 29,705K outstanding shares. Right now, sales total 3,950 K and income totals -24,990 K. The company made 850 K in profit during its latest quarter, and -5,370 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.